No Data
No Data
CCORF Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $9
Edward Nash Recommends Buy on Rezolute, Sets $9 Target Amidst Product Progress and Regulatory Advancements
H.C. Wainwright Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $14
Rezolute Executive Wladimir Hogenhuis Buys $20,017 in Company Stock
BTIG Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $15
Analysts' Opinions Are Mixed on These Healthcare Stocks: Rezolute (RZLT) and Gryphon Digital Mining (GRYP)
No Data
No Data